Meir Perez Pugatch

Intellectual Property: Patent Pools and Collaborative Initiatives: Assessing the Efficacy of Alternatives to IP in the Development of New Pharmaceutical Drugs, Especially for Neglected Diseases – An Empirical Analysis


European Journal of Risk Regulation 4/2011: pp. 566-571

€ 23,80 (including 19 % tax)


This article examines the issue of risk in research and development (R&D) pertaining to new pharmaceuticals, especially those aimed at neglected diseases and/ or relevant primarily to the developing world. In particular, the article considers the role of patent pools and other forms of non-proprietary models as alternatives to patents (and other types of intellectual property rights) in R&D for new pharmaceuticals. The article concludes that that these mechanisms still achieve very little output and can therefore not currently be considered as viable alternatives to the use of patents in pharmaceutical R&D. Another relevant finding is that many of the existing collaborative initiatives and partnerships for R&D in neglected diseases actually rely on different forms of intellectual property rights.
  

Shopping cart

 Price Delete
Your cart is currently empty.
Subtotal*
*excl. shipping costs Buy now

EStAL
Journal
Publication frequency: quarterly
Subscription: € 442,-
ISSN 16 19-52 72

Further information

Reading of Intimate Brussels - Living amongst Eurocrats

30 March 2011, 18.30 pm @ European Parliament

For one year, Martin Leidenfrost explored Europe’s capital and wrote fifty personal – tender, alienated, mischievous – portraits.

“Entertaining, amusing, insightful.” The Gap